Correspondence

Ivermectin for COVID-19: Promising but not yet conclusive

Bookmark and Share
R van Rensburg, E H Decloedt, H Reuter, A Parker, N Schrueder, S Lahri

Authors' affiliations

R van Rensburg, Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa

E H Decloedt, Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa

H Reuter, Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa

A Parker, Division of Infectious Diseases, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa

N Schrueder, Division of General Internal Medicine, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa

S Lahri, Emergency physician, Khayelitsha Hospital; and Division of Emergency Medicine, Department of Family Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa

Full Text

PDF (66KB)

Cite this article

South African Medical Journal 2021;111(3):188. DOI:10.7196/SAMJ.2021.v111i3.15522

Article History

Date submitted: 2021-01-12
Date published: 2021-01-12

Article Views

Abstract views: 19759
Full text views: 1671

Comments on this article

*Read our policy for posting comments here